Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Anticoagulants and Immunosuppressives in Behçet’s Syndrome
Arisa Chuklin/LinkedIn
Oct 22, 2025, 04:29

Anticoagulants and Immunosuppressives in Behçet’s Syndrome

Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:

”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert

• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.”

Title: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis

Authors: Arisa Chuklin, Thita Chiasakul, Noppacharn Uaprasert

Anticoagulants

Read the article here.

Stay updated on all scientific advances with Hemostasis Today.

anticoagulants Arisa Chuklin Behçet’s Syndrome Hematology Hemostasis Today Immunosuppressive Therapy Journal of Thrombosis and Haemostasis JTH Medicine Meta-analysis Noppacharn Uaprasert Systematic Review Thita Joy Chiasakul thrombosis
NewsFeed